Dr. Anas Diab, MD

Dr. Diab practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Diab's NPI, 1275608663, was assigned on November 21, 2006. Dr. Diab holds West Virginia license 20006.

Dr. Diab's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Diab's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Diab is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Diab to 4 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diab practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Diab's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Diab is licensed in West Virginia.

CMS data shows 462 Medicare services from Dr. Diab across 8 procedure codes in 2024, for 205 Medicare patients. Medicare paid $61,783 for them.

CMS counts 205 Medicare patients who saw Dr. Diab in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diab's median patient age at 73, with 50% women.

In 2024, Dr. Diab wrote 548 Medicare Part D claims for 108 patients. 79% of them were for generic drugs. CMS names the drug for 402 of them, across 20 drugs with 11 or more claims each, at $112,212 in total drug cost. In 2023, CMS named 311 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Diab for performance year 2024, reported through an alternative payment model (APM). Dr. Diab accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Diab as offering telehealth.

Dmand AI links 3 papers to Dr. Diab, published from 2018 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Kidney Failure, Chronic. Dr. Diab's most frequent co-authors are Sami Aljohani, MD, Vinay Badhwar, MD and Chalak O. Berzingi, MD.

CMS Open Payments shows 21 general payments to Dr. Diab from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Travere Therapeutics, Inc. paid the most, $143.